FNY Investment Advisers »

Context Therapeutics shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $15k 6.0k 2.50

More positions owned by FNY Investment Advisers

Global X Fds global x copper (COPX)
Codere Online Luxembourg Ord (CDRO)
Sealed Air
Clearw.a.hld. (CWAN)
Fonar Corporation (FONR)
Wix (WIX)
Deere & Company (DE)
Amicus Therapeutics (FOLD)
Futurecrest Acquisition Corp (FCRS.U)
Seabridge Gold (SA)
Cme (CME)
Norfolk Southern (NSC)
Willow Lane Acquisition Corp (WLAC)
Terns Pharmaceuticals (TERN)
Astrazeneca Plc Ord (AZN)

View all positions for FNY Investment Advisers

Top funds holding Context Therapeutics

MPM Oncology Impact Management
Blue Owl Capital Holdings
Nextech Invest
Deep Track Capital
Soleus Capital Management
Octagon Capital Advisors
Avidity Partners Management
Franklin Resources
Vanguard Group
Vanguard Capital Management
TCG Crossover Management
Marshall Wace
Dr. Jeffrey R. Jay, M.D.
Millennium Management
Sio Capital Management

View all funds holding Context Therapeutics